California News Observer
SEE OTHER BRANDS

The most trusted news from California

California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on May 12, 2025

Fluence Energy, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 12, 2025 Deadline to file Lead Plaintiff Motion.

Fluence Energy, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 12, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fluence Energy, Inc. ("Fluence" or the "Company") (NASDAQ: FLNC) investors of a class …

Knowpia Inc. Presents STO+ Compliance Framework to SEC, Embraces US Digital Asset Reform

Knowpia Inc. Presents STO+ Compliance Framework to SEC, Embraces US Digital Asset Reform

Funs.AI unveils STO+ to SEC, aligning with U.S. crypto reform to bridge utility and compliance, paving the way for regulated, user-driven Web3 platforms. FREMONT, CA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- In a significant step forward for …

Teaching with Grit and Grace: Coach Stewart’s Real-Life Guide to Reaching Challenging Students

Teaching with Grit and Grace: Coach Stewart’s Real-Life Guide to Reaching Challenging Students

Veteran educator Coach Stewart shares transformative teaching methods and classroom strategies drawn from 38 years of real-life experience. CRESTLINE, CA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- Coach Thomas Stewart, an Ohio educator with 34 …

Krispy Kreme, Inc. Investors: Company Investigated by the Portnoy Law Firm

Krispy Kreme, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Krispy Kreme, Inc. (“Krispy Kreme” or “the Company”) (NASDAQ: DNUT) investors that the firm …

New Home Co. to Acquire Landsea Homes Corporation, Creating a Top 25 National Homebuilder

New Home Co. to Acquire Landsea Homes Corporation, Creating a Top 25 National Homebuilder

Landsea Homes Shareholders to Receive $11.30 Per Share in Cash, Representing a Premium of Approximately 61% to the Closing Share Price on May 12, 2025 Complementary, Diversified Footprint Positions Combined Company to Accelerate Continued Growth Across the …

SUMiT Releases Soul-Stirring New Album Find a Way

SUMiT Releases Soul-Stirring New Album Find a Way

An introspective 8-track journey of faith, resilience, and self-discovery, SUMiT invites listeners into his heart with his most personal project to date. WORCESTER, CA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- SUMiT has officially released his …

Provident Financial Holdings Announces CFO Appointment

Provident Financial Holdings Announces CFO Appointment

RIVERSIDE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Provident Financial Holdings, Inc. (“Company” or “Provident”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank” or “Provident”), today announced that Peter C. Fan has been …

 New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide …

KBRA Affirms Ratings for Heritage Commerce Corp

KBRA Affirms Ratings for Heritage Commerce Corp

SAN JOSE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Heritage Commerce Corp (NASDAQ: HTBK) (the "Company"), parent company of Heritage Bank of Commerce (the "Bank"), announced today that Kroll Bond Rating Agency, LLC ("KBRA") affirmed the Company’s senior …

Life360 Reports Record Q1 2025 Results

Life360 Reports Record Q1 2025 Results

Monthly Active Users Reached Approximately 83.7 million Record Q1 Global Net Additions to Paying Circles of 137 thousand - Reaching 2.4 million Total Total Quarterly Revenue Grew 32% Year-Over-Year to $103.6 million Annualized Monthly Revenue increased 38% …

 Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

– Strategic transformation to innovative oncology completed in Q2 2025 – – Positive CHS-114 (anti-CCR8 antibody) Phase 1b dose expansion study data in patients with head and neck cancer presented at 2025 AACR Annual Meeting – – Additional CHS-114 Phase 1b …

Maravai Lifesciences Reports First Quarter 2025 Financial Results

Maravai Lifesciences Reports First Quarter 2025 Financial Results

SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first …

Rigetti Computing Reports First Quarter 2025 Financial Results

Rigetti Computing Reports First Quarter 2025 Financial Results

BERKELEY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the first quarter ended March 31, 2025. …

Oncocyte Reports Q1 2025 Results and Business Progress

Oncocyte Reports Q1 2025 Results and Business Progress

Q1 2025 pharma services revenue of $2.1 million, at 62% gross margin Three of the top 10 U.S. transplant centers expected to participate in clinical trial Ten globally leading transplant hospitals are now using our GraftAssure research-use-only kits To …

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

BDC-4182 Phase 1 dose-escalation study now open for enrollment BDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity, and monotherapy anti-tumor activity Bolt is running a …

Lantronix Appoints Sailesh Chittipeddi to Its Board of Directors

Lantronix Appoints Sailesh Chittipeddi to Its Board of Directors

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Sailesh Chittipeddi, Ph.D., has joined the Lantronix Board of …

Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors

Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors

CARLSBAD, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced the appointments of  Dr. William “Bill” LaPlante and Michael Paull to its Board of Directors, effective immediately …

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 152, …

Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven …

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update

Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $100 million Transaction …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service